Concepta Diagnostics Ltd. engages in the development of products for the female health diagnostics sector. The company was founded by Steven Koon Ching Lee and Robert Andrew Porter on January 15, 2013 and is headquartered in Cardiff, the United Kingdom.

Nestec SA, a subsidiary of Nestlé SA, is a Swiss company located in Vevey. The firm manufactures nutrition food products.

Kun Mingwo Biotechnology Co., Ltd., established on 2016-08-19, Business scope includes licensed projects:Veterinary drug business;Production of Class II Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Production of Class I Medical Devices;(The above business scope does not involve the scope of special management measures for the access of foreign-invested enterprises)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

NX Prenatal is a private molecular diagnostics company developing diagnostic assays for adverse pregnancy conditions such as preterm birth. It employs the proprietary NeXosome platform, which enables advanced isolation and enrichment of exosome and microvesicle particles from bodily fluids for non-invasive biomarker evaluation.

Zaporizhzhia State Medical University (ZSMU) is a medical university in the small city of Zaporizhzhia, Ukraine.

Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.

Chiron Diagnostics Corp., a subsidiary of Bayer AG, is a company headquartered in East Walpole, MA. The firm develops medical diagnostic products. On November 30, 1998 Bayer AG acquired Chiron Diagnostics Corp. from Chiron Corp. for $1,100 million.

G.L. Pharma was formed out of a merger of the two pharmaceutical companies Gerot and Lannacher and is looking back at a history of more than 70 years. They develop, produce and allocate unique brand name products as well as generics for the well-being of people in Austria and abroad. As a supplier to Austria’s healthcare sector, they partner with general practitioners, pharmacists, their patients and pharmaceutical wholesalers.

Sichuan Huiyuan Agriculture and Animal Husbandry Technology Co., Ltd., established on 2008-04-03, The scope of business includes the development of new technologies in agriculture and animal husbandry,Research,application.farming,Sales:live pig,sow,fish;to plant,Sales:vegetable.Acquisition of agricultural and sideline products.Wholesale and retail:Pre-packaged food(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Blue Cross Biopharmaceutical (Beijing) Co., Ltd., established on 2002-08-30, The scope of business includes the production of biological products,genetically engineered product;Provide technical consultation and technical services for self-produced products;Sell ​​self-produced products;Production2002Catalog:Class III:III-6840In vitro diagnostic reagents,Class II:II-6840In vitro diagnostic reagents,2017Catalog:Class II:II-22-04Fluorescence Immunochromatography Analyzer.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production2002Catalog:Class III:III-6840In vitro diagnostic reagents,Class II:II-6840In vitro diagnostic reagents,2017Catalog:Class II:II-22-04Fluorescence immunochromatography analyzer and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Pantarhei Bioscience BV (PRB) is a limited liability company (Besloten Vennootschap) located in the Netherlands focussing on the development of innovative concepts for woman’s health and hormone-related cancer treatments. PRB has founded a subsidiary company – Pantarhei Oncology (PRO) – to develop treatments for Endocrine Cancer. PRB has developed a product pipeline based on its ability to identify novel medical uses of existing molecules, drugs, hormones, biologicals and combinations thereof in these areas of medicine. The main areas of expertise of PRB are reproductive hormone related treatments and diseases such as contraception and menopausal hormone therapy (MHT). The main areas of expertise of PRO are breast cancer, prostate cancer and ovarian cancer . PRB develops patent protected new treatment concepts up to proof-of-concept (PoC) in the human (phase II). Using existing molecules often provides first evidence of safety. The business model of the Pantarhei companies is based on creating intellectual property (IP) of new concepts ad inventions, in-house project management and outsourcing of all research and development activities. After successful PoC, data and IP are licensed out to a licensee or partner for completion of clinical development (phase III), regulatory approval and sales and marketing by a licensee/partner.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Welgene Biotech Co., Ltd. engages in the provision of biotechnology services including genetic testing, molecular diagnosis, and bioinformatics support for universities, hospitals, pharmaceutical companies, and others. It operates through the following business segments: Biotechnology testing segment and Biotechnology medical equipment sale segment. The Biotechnology testing segment provides testing services, while the Biotechnology medical equipment sale segment engages in the trading of medical equipment. The company was founded by Fu Chien Chen on January 30, 2003 and is headquartered in Taipei, Taiwan.

The Texas A&M University System creates a seamless pathway for students to earn an associate and bachelor’s degree in related fields

Yi Shi Bio is a joint venture and a leading IVD solution provider. With manufacturing facilities in Beijing, Nantong, and Wuxi, Yi Shi Bio develop, produce, and distribute diagnostic kits all over the world. Their products include Rapid Tests, Elisa kits, CLIA and POCT analyzer systems, and they have registered the trade mark EGENS. To date, EGENS has received certification for its quality management systems (QMS) under the following standards: ISO9001, ISO13485 CMDR, ISO14001, OSHAS18001, and GMP.

Ningbo Aocheng Biotechnology Co., Ltd., established on 2009-02-16, Business scope includes general items:Biochemical product technology research and development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Class II Medical Device Leasing;Class I Medical Device Leasing;software development;Artificial intelligence application software development;Information Technology Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Network and Information Security Software Development;Information system operation and maintenance services;Wholesale of computer software, hardware and auxiliary equipment;Medical Research and Experimental Development;Conference and Exhibition Services;Technology Import and Export;Import and export;market survey(Does not include foreign investigations);Bidding agency service;marketing planning;Mechanical Parts,Parts sales;Instrument sales;Machinery sales;electronics sales;Experimental analysis instrument sales;software sales;Office Supplies Sales;Glassware Sales;Sales of plastic products;Sales of technical glass products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Class III Medical Device Leasing;Class III medical device business;Production of Class III Medical Devices;food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.